- Report
- March 2025
- 196 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- April 2025
- 511 Pages
Global
From €5317EUR$5,850USD£4,515GBP
- Report
- April 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,466GBP
- Report
- March 2025
- 175 Pages
Global
From €4081EUR$4,490USD£3,466GBP
- Report
- February 2025
- 312 Pages
Global
From €4545EUR$5,000USD£3,859GBP
- Report
- January 2025
- 293 Pages
Global
From €4545EUR$5,000USD£3,859GBP
- Report
- July 2024
- 158 Pages
Global
From €3284EUR$3,613USD£2,788GBP
€3863EUR$4,250USD£3,280GBP
- Report
- January 2025
- 578 Pages
Global
From €4499EUR$4,950USD£3,821GBP
- Report
- July 2024
- 308 Pages
Global
From €1493EUR$1,643USD£1,268GBP
€1991EUR$2,190USD£1,690GBP
- Report
- March 2025
- 195 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- April 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,466GBP
- Report
- September 2024
- 138 Pages
Global
From €2726EUR$2,999USD£2,315GBP
- Report
- May 2024
- 125 Pages
Global
From €5408EUR$5,950USD£4,592GBP
- Report
- April 2025
- 174 Pages
Global
From €5317EUR$5,850USD£4,515GBP
- Report
- April 2025
- 181 Pages
Global
From €5317EUR$5,850USD£4,515GBP
- Report
- April 2025
- 175 Pages
Global
From €4081EUR$4,490USD£3,466GBP
- Report
- April 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,466GBP
- Report
- February 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,466GBP
- Report
- February 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,466GBP
- Report
- January 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,466GBP

The HbA1C Testing market within the Biotechnology industry is a rapidly growing sector. It is used to measure the average amount of glucose in the blood over a period of two to three months. This test is used to diagnose and monitor diabetes, as well as to assess the effectiveness of diabetes treatments. It is also used to detect pre-diabetes and to monitor the risk of developing diabetes.
The HbA1C Testing market is driven by the increasing prevalence of diabetes, the growing awareness of the importance of early diagnosis and treatment, and the availability of advanced testing technologies. The market is also supported by the increasing demand for point-of-care testing and the development of new products.
Some of the major companies in the HbA1C Testing market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Alere, and Bio-Rad Laboratories. Show Less Read more